Aura Biosciences (Aura) announced some progress in the development of its platform technology, NanoSmart. Investors forked out another $4 million for Aura to enter clinical trails as promising preclinical data showed that NanoSmart's Nanosphere Particles successfully...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)